Filed pursuant to Rule 424(b)(5)
Registration No. 333-238149
PROSPECTUS SUPPLEMENT
(to Prospectus dated May 11, 2020)
$300,000,000
PENN NATIONAL GAMING, INC.
2.75% Convertible Senior Notes due 2026
We are offering $300 million aggregate principal amount of 2.75% convertible senior notes due 2026, which we refer to in this prospectus supplement as the “notes.” Throughout this prospectus supplement, we refer to this offering of notes as the “Notes Offering.” We have also granted the underwriters an option to purchase up to $45 million of additional aggregate principal amount of notes from us within 30 days from the date of this prospectus supplement to cover over-allotments, if any.
We will pay interest on the notes at an annual rate of 2.75%, payable semi-annually in arrears on May 15 and November 15 of each year, beginning on November 15, 2020. The notes will mature on May 15, 2026, unless earlier repurchased, redeemed or converted.
Prior to the close of business on the business day immediately preceding February 15, 2026 (the “free convertibility date”), noteholders may convert their notes at their option only in the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020, if the last reported sale price per share of our common stock for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter, exceeds 130% of the conversion price then in effect on each applicable trading day, as determined by us in good faith; (2) during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) if the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day, subject to compliance with certain procedures and conditions described in this prospectus supplement; (3) following the occurrence of certain specified corporate events or distributions on our common stock, as described in this prospectus supplement; and (4) if we call such notes for redemption (but solely, subject to certain exceptions, with respect to such notes called for redemption). At any time from, and including, the free convertibility date until the close of business on the second scheduled trading day immediately before the maturity date, noteholders may convert their notes at their option regardless of the foregoing conditions. We will settle conversions by paying or delivering, as applicable, at our election, cash, shares of our common stock or a combination of cash and shares of our common stock, based on the applicable conversion rate(s). If we elect to deliver cash or a combination of cash and shares of our common stock, then the consideration due upon conversion will be determined over an observation period consisting of 40 “VWAP trading days” (as defined in this prospectus supplement). The initial conversion rate is 42.7350 shares per $1,000 principal amount of notes, which represents an initial conversion price of approximately $23.40 per share, and is subject to adjustment as described in this prospectus supplement. If a “make-whole fundamental change” (as defined in this prospectus supplement) occurs, then we will in certain circumstances increase the conversion rate for a specified period of time.
The notes will be redeemable, in whole or in part, at our option at any time, and from time to time, on or after November 20, 2023 and on or before the 45th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the redemption date, but only if the last reported sale price per share of our common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date we send the related redemption notice; and (2) the trading day immediately before the date we send such notice. In addition, calling any note for redemption will constitute a make-whole fundamental change with respect to that note, in which case the conversion rate applicable to the conversion of that note will be increased in certain circumstances if it is converted after it is called for redemption.
If a “fundamental change” (as defined in this prospectus supplement) occurs, then noteholders will have the right to require us to repurchase their notes at a cash repurchase price equal to the principal amount of the notes to be repurchased, plus accrued and unpaid interest thereon, to, but excluding, the fundamental change repurchase date.
The notes will be our unsecured, unsubordinated obligations and will be equal in right of payment with our existing and future unsecured, unsubordinated indebtedness, senior in right of payment to our existing and future indebtedness that is expressly subordinated in right of payment to the notes and effectively subordinated to our existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness. The notes will be structurally subordinated to all existing and future indebtedness and other liabilities, including accounts payables, and (to the extent we are not a holder thereof) preferred equity, if any, of our subsidiaries.
No public market currently exists for the notes, and we do not intend to apply to list the notes on any securities exchange or any automated dealer quotation system. Our common shares are listed on the NASDAQ Global Select Market under the symbol “PENN.” The last reported closing price of our common shares on the NASDAQ Global Select Market on May 11, 2020 was $18.66 per share.
Concurrently with the Notes Offering, we are conducting a public offering of 16,666,667 common shares (or 2,500,000 additional common shares from us at the public offering price, less the underwriting discount, if the underwriters in the Concurrent Common Stock Offering exercise their option to purchase additional common shares in full). Neither the completion of the Notes Offering nor the Concurrent Common Stock Offering is contingent on the completion of the other, so it is possible that the Notes Offering occurs and the Concurrent Common Stock Offering does not occur, and vice versa. We cannot assure you that the Concurrent Common Stock Offering will be completed on the terms described herein, or at all. The Concurrent Common Stock Offering is being made pursuant to a separate prospectus supplement, and nothing contained herein shall constitute an offer to sell or the solicitation of an offer to buy common shares to be issued in the Concurrent Common Stock Offering. See “Concurrent Common Stock Offering.”
We intend to use the net proceeds from the Notes Offering and the Concurrent Common Stock Offering for general corporate purposes.
None of the U.S. Securities and Exchange Commission, any state securities commission, any state gaming commission or any other gaming authority or other regulatory agency has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
| | | Per Note | | | Total | |
Public Offering Price(1) | | | | $ | 1,000 | | | | | $ | 300,000,000 | | |
Underwriting discounts and commissions(2) | | | | $ | 25 | | | | | $ | 7,500,000 | | |
Proceeds, before expenses, to us | | | | $ | 975 | | | | | $ | 292,500,000 | | |
(1)
Plus accrued interest, if any, from May 14, 2020, if settlement occurs after that date
(2)
See “Underwriting” for a description of the compensation payable to the underwriters
Investing in the notes involves risks. Please carefully consider the “Risk Factors” beginning on page S-6 and the “Risk Factors” section contained in the documents incorporated by reference herein. The underwriters expect to deliver the notes to investors in book-entry form through The Depository Trust Company on or about May 14, 2020.
Joint Book-Running Managers
| Goldman Sachs | | | BofA Securities | |
Book-Running Managers
| J.P. Morgan | | | Fifth Third Securities | | | Wells Fargo Securities | |
Co-Managers
| SunTrust Robinson Humphrey | | | Barclays | | | Citizens Capital Markets | | | Macquarie Capital | |
| Morgan Stanley | | | Stifel | | | TD Securities | | | US Bancorp | |
The date of this prospectus supplement is May 11, 2020.